Omi Group and KEAN Health to Partner on Healthcare DX Using Genomic Data
Published
Omi Group, a Japanese company group, and KEAN Health have agreed to work together to advance digital transformation (DX) in the medical and healthcare fields. The two companies also plan to cooperate in the Vietnamese medical market.
Through this partnership, they will strengthen four areas. The first is promoting healthcare DX with genomic (gene) data at its centre. The second is expanding into the Vietnamese market. The third is supporting each other's development. The fourth is carrying out joint research.
Genomic data is attracting attention as information that can help prevent and treat diseases. The two companies aim to develop services and technologies that use this data together and expand them into the Vietnamese market. In Vietnam, interest in medicine and healthcare is growing along with economic growth.
Attention is now focused on what specific products and services the two companies will announce. DX in the medical field has also become an important theme in Japan, and this initiative is likely to draw interest as a new example of Japanese companies working together in Asian markets.
Sources: VIETJOベトナムニュース
More Japan news
- JTB to Overhaul Its Network Across the Head Office and Osaka Office as They Move
- Government Sets Up Think Tank to Analyse Advanced Technology Information
- Defence-Themed Investment Trust "GX Defence Tech" Stock Price Information Published
- 衆議院の比例代表31減の法案、特別委員会で審議入り
- Attention on Takaichi's contact with China as relations stay cold; tomorrow's "welcome" is the focus
- South Korean Progressive Party Research Head Denied Entry to Japan
- U.S. President Trump to Arrive in Manila Soon, Japan-U.S.-Australia-India Unity in Focus
- Community-Based Health Work in Nepal Offers Ideas for Japan's Doctor Shortage